CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $77,000 | -78.6% | 36,200 | -54.8% | 0.01% | -66.7% |
| Q2 2017 | $360,000 | +200.0% | 80,000 | +100.0% | 0.03% | +57.9% |
| Q1 2017 | $120,000 | +50.0% | 40,000 | +38.4% | 0.02% | +46.2% |
| Q4 2016 | $80,000 | -11.1% | 28,900 | 0.0% | 0.01% | -7.1% |
| Q3 2016 | $90,000 | -39.2% | 28,900 | 0.0% | 0.01% | -46.2% |
| Q2 2016 | $148,000 | +51.0% | 28,900 | +20.9% | 0.03% | +73.3% |
| Q1 2016 | $98,000 | -48.4% | 23,900 | +2.1% | 0.02% | -40.0% |
| Q4 2015 | $190,000 | -3.6% | 23,400 | 0.0% | 0.02% | -47.9% |
| Q3 2015 | $197,000 | -10.5% | 23,400 | 0.0% | 0.05% | +71.4% |
| Q2 2015 | $220,000 | +58.3% | 23,400 | +56.0% | 0.03% | +47.4% |
| Q1 2015 | $139,000 | – | 15,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,241,550 | $7,520,000 | 4.03% |
| Tamarack Advisers, LP | 1,875,000 | $4,350,000 | 2.07% |
| CLOUGH CAPITAL PARTNERS L P | 2,075,663 | $4,816,000 | 0.46% |
| Rock Springs Capital Management LP | 1,200,000 | $2,784,000 | 0.12% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,192,034 | $9,726,000 | 0.08% |
| PUTNAM INVESTMENTS LLC | 3,092,133 | $7,174,000 | 0.02% |
| Renaissance Technologies | 528,913 | $1,227,000 | 0.00% |
| SCOTIA CAPITAL INC. | 19,120 | $44,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 51,200 | $118,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 700 | $2,000 | 0.00% |